Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs meropenem for hospital-acquired pneumonia
CTR20150065Phase 3Active
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doripenem in hospital-acquired pneumonia (HAP), sponsored by Shionogi & Co., Ltd.. Started Feb 2015; status: active.
02
Drugs
doripenem
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on CTR20150065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150065.